This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Back

Blog

| less than a minute read

Hope for Alzheimer's sufferers

A new drug has been trialled for the treatment of Alzheimer's. It is hoped that the drug can slow the progress of the disease that affects an ever-increasing number of people. 

Although this is good news this new treatment is ineffective for other forms of dementia, such as vascular dementia. It is also unclear how the NHS will fund the drug and how and if it will be rolled out nationally. There is still a long way to go before we can take treatment for granted.

It highlights the ever-present need for people to make lasting powers of attorney (LPAs) while they have capacity and to seek legal advice on estate planning.  

Asked if the government were prepared to invest where needed to roll out new treatments, Mr Cameron said there was a real incentive to do so: "We're a country of sixty million people, with a million people with dementia, many of them in very expensive residential care settings and so there is a lot of savings to be had from effectively treating people….I'm hopeful that our system can deliver."

To make sure you receive all of our latest insights, subscribe here.